Amgen, Inc. vs Capri Holdings Ltd — how do they compare? Amgen, Inc. trades at $412.77 (market cap $224.14B), while Capri Holdings Ltd trades at $15.62 (market cap $1.75B). The key difference: Amgen, Inc. is far larger — about 128.1× Capri Holdings Ltd's market cap, and Amgen, Inc. pays a 2.43% dividend while Capri Holdings Ltd pays none. Which is the better fit depends on your goals.
| AMGN | CPRI | |
|---|---|---|
Market Cap | $224.14B | $1.75B |
Sector | Health | Consumer Staples |
52-Week High | $417.20 | $27.66 |
52-Week Low | $271.18 | $14.98 |
Enterprise Value | $267.45B | $3.03B |
Dividend Yield | 2.43% | — |
Trailing returns across standard periods
Latest headlines on both assets
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 800 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
Read more on CPRI →